Skip to content

Exploring effectiveness of intravenous Dexmedetomidine versus Tramadol in participants for post spinal anesthesia shivering management and comparison of the two drugs and understanding the primary outcome.

Comparison of intravenous Dexmedetomidine vs Tramadol as anti-shivering agent following spinal anesthesia - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065749
Enrollment
64
Registered
2024-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration Health Condition 2: 4- Measurement and Monitoring Health Condition 3: 8- Other Procedures

Interventions

Intervention1: Comparison between Dexmedetomidine and Tramadol as anti-shivering agent post spinal anesthesia: Patients shall be visited on the evening prior to surgery They shall be re evaluated and

Sponsors

Eras medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American society of anesthesiologists (ASA) physical status grade 1 and 2, patients who develop shivering post sub arachnoid block (spinal anesthesia)

Exclusion criteria

Exclusion criteria: patient refusal, pregnancy, patients with known hypersensitivity to study drugs, ischemic heart disease, hepatic disease, hyperthyroidism, hypothyroidism, urinary tract infection, diabetes mellitus, known history of substance or alcohol abuse

Design outcomes

Primary

MeasureTime frame
the primary outcome of the study is to compare the effectiveness of intravenous dexmedetomidine versus tramadol as a anti shivering agent post spinal anesthesia and better agent that helps in subsiding the shivering faster with least amount of side effects.Timepoint: time noted after onset of shivering and time taken to subside the shivering. vitals measured at every 5 minute interval till 30 minutes and every 15 minutes till end of surgery.

Secondary

MeasureTime frame
side effects to be noted such as nausea, vomiting, bradycardia etcTimepoint: at the end of study

Countries

India

Contacts

Public ContactDr Prof Maj Sanjay Choubey

Eras medical college and hospital

sanjay.choubey@yahoo.com8840155309

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026